Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Composition: M11 Report Section 2 (Introduction) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

version: 8; Last updated: 2026-08-05 01:20:29+0000

Profile: M11ReportSection02

Artifact Description:

Example of M11ReportSection02 Profile

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/Composition/568059

identifier: FEvIR Object Identifier/568059

status: Final

type: CeSHarP Report

category: section2-introduction

date: 2026-08-05 01:20:29+0000

author: Brian S. Alper, MD, MSPH

title: M11 Report Section 2 (Introduction) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

custodian: Computable Publishing LLC

relatesTo

type: Derived from

target: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

relatesTo

type: Cite As

target:

M11 Report Section 2 (Introduction) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568059. Revised 2026-08-05. Available at: https://fevir.net/resources/Composition/568059. Computable resource at: https://fevir.net/resources/Composition/568059#json.